Amdocs LtdShs Aktie
WKN: 915119 / ISIN: GB0022569080
09.05.2017 22:33:47
|
Amdocs Updates FY17 Revenue Growth Outlook - Quick Facts
(RTTNews) - Amdocs Limited (DOX) announced, for fiscal 2017, the company now expects revenue growth of 3.5-5.5% year-over-year on a constant currency basis compared with previous guidance of 2.5-6.5% year-over-year. As reported, revenue growth is expected to be in a range of 3.0-5.0% year-over-year. The company reiterated fiscal 2017 Non-GAAP EPS growth outlook of 4.5-8.5% year-over-year.
The company's GAAP net income for the second quarter of fiscal 2017 was $112.6 million, or $0.76 per share, compared to $107.7 million, or $0.71 per share, in the prior fiscal year's second quarter. Net income on a non-GAAP basis was $139.2 million, or $0.94 per share, compared to $140.2 million, or $0.92 per share, last year. Revenue for the second fiscal quarter was $966.0 million, up 4.3% as compared to last year's second fiscal quarter.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Amdocs LtdShsmehr Nachrichten
22.04.25 |
Erste Schätzungen: Amdocs zieht Bilanz zum abgelaufenen Quartal (finanzen.net) | |
03.02.25 |
Ausblick: Amdocs mit Zahlen zum abgelaufenen Quartal (finanzen.net) | |
20.01.25 |
Erste Schätzungen: Amdocs stellt Ergebnisse des abgelaufenen Quartals vor (finanzen.net) | |
11.11.24 |
Ausblick: Amdocs legt Zahlen zum jüngsten Quartal vor (finanzen.net) |
Analysen zu Amdocs LtdShsmehr Analysen
Aktien in diesem Artikel
Amdocs LtdShs | 74,78 | -0,80% |
|